Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
NCT00250640
·
clinicaltrials.gov ↗
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension, Pulmonary
Interventions
DRUG:
Iloprost (Ventavis, BAYQ6256)
Sponsor
Bayer